The Best Offense Is a Good Defense: Patent Prosecution Strategies During Personalized Medicine Drug Development

Robert C. Millonig, Jr., Ph.D., Marsha Rose Gillentine, Ph.D. and Rebecca Hammond recently published an article in the February 2015 issue of Biotechnology Law Report. The article covers the merits of personalized medicine, and how the plethora of advanced technology surrounding it presents complex patent challenges. The article provides a legal protocol for filing initial personalized medicine patent applications, filing subsequent patent applications, drafting patentable claims, and ensuring a diverse patent portfolio.

To view the full article, please read it online here.